Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Moore

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Journal of Consulting and Clinical Psychology|April 16, 2002
Metacognitive awareness and prevention of relapse in depression: empirical evidenceJohn D Teasdale, Richard G Moore, Hazel Hayhurst, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterusRichard G Moore, Craig Michael Miller, Amy K Brown, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 19, 2014
Predictive factors for the presence of malignant transformation of pelvic endometriosisYfat Kadan, Stephen Fiascone, Carolyn McCourt, et al.
Chemical Communications (Cambridge, England)|December 18, 2014
Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acidLei Wang, Martha Sibrian-Vazquez, Jorge O Escobedo, et al.
Scientific Reports|July 1, 2014
HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocationElizabeth Lokich, Rakesh K Singh, Alex Han, et al.
Journal of Palliative Medicine|February 15, 2007
Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancerMary E Gordinier, Don S Dizon, Sherry Weitzen, et al.
Plos One|May 12, 2011
Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generationKyu Kwang Kim, Rakesh K Singh, Robert M Strongin, et al.
Plos One|May 5, 2020
Role of trypsin and protease-activated receptor-2 in ovarian cancerKyu Kwang Kim, Rachael Turner, Negar Khazan, et al.
Gynecologic Oncology|June 12, 2003
Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulvaRichard G Moore, Stephen E DePasquale, Margaret M Steinhoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 23, 2025
The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatmentAlexandra Morell, Anne Stoklosa, Alexandra Blackman, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Journal of Consulting and Clinical Psychology|April 16, 2002
Metacognitive awareness and prevention of relapse in depression: empirical evidenceJohn D Teasdale, Richard G Moore, Hazel Hayhurst, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterusRichard G Moore, Craig Michael Miller, Amy K Brown, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 19, 2014
Predictive factors for the presence of malignant transformation of pelvic endometriosisYfat Kadan, Stephen Fiascone, Carolyn McCourt, et al.
Chemical Communications (Cambridge, England)|December 18, 2014
Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acidLei Wang, Martha Sibrian-Vazquez, Jorge O Escobedo, et al.
Scientific Reports|July 1, 2014
HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocationElizabeth Lokich, Rakesh K Singh, Alex Han, et al.
Journal of Palliative Medicine|February 15, 2007
Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancerMary E Gordinier, Don S Dizon, Sherry Weitzen, et al.
Plos One|May 12, 2011
Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generationKyu Kwang Kim, Rakesh K Singh, Robert M Strongin, et al.
Plos One|May 5, 2020
Role of trypsin and protease-activated receptor-2 in ovarian cancerKyu Kwang Kim, Rachael Turner, Negar Khazan, et al.
Gynecologic Oncology|June 12, 2003
Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulvaRichard G Moore, Stephen E DePasquale, Margaret M Steinhoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 23, 2025
The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatmentAlexandra Morell, Anne Stoklosa, Alexandra Blackman, et al.
Pageof 12